Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CORPORATEGOVERNANCE<br />
Our Directors and management are committed to high standards of corporate governance in order to<br />
protect the interests of our employees, customers and Shareholders, and follow closely the best practices<br />
outlined in the Best Practices Guide issued by the Singapore Exchange Securities Trading Limited (SGX-ST):<br />
Board of Directors<br />
Our Board of Directors, comprising seven members, is made up of 3 executive Directors and 4 non-<br />
executive Directors. The Chairman / Chief Executive Officer Dr Ron Sim Chye Hock, the Chief Operating<br />
Officer Mr Teo Chay Lee and the Regional General Manager Mr Leow Lian Soon are the executive directors.<br />
The non-executive directors are Ms Teo Sway Heong, Mr Khor Peng Soon, Mr Michael Kan Yuet Yun and<br />
Mr Ong Kian Min.<br />
The Board will meet periodically throughout the year. To assist the Board of Directors in discharging its<br />
responsibilities, we have the following Committees:-<br />
The Executive Committee<br />
The Executive Committee comprises the 3 executive Directors, Dr Ron Sim Chye Hock, Mr Teo Chay Lee,<br />
Mr Leow Lian Soon and the Chief Financial Officer Mr Lee Hwai Kiat. The Committee will assist the Board<br />
to strengthen our management culture and direct the Group towards fulfilling our vision of being a global<br />
brand name in home health care products. The Committee will also assist the Board to allocate resources<br />
of the Group after considering the risks and returns associated with our operations, including business and<br />
financial risks;<br />
Audit Committee<br />
The Audit Committee comprises 2 independent Directors, Mr Michael Kan Yuet Yun, Mr Ong Kian Min and<br />
1 executive Director, Mr Teo Chay Lee. Mr Michael Kan Yuet Yun is the Chairman of the Audit Committee.<br />
The main objective of the Committee is to assist the Board of Directors in fulfilling the fiduciary responsibilities<br />
of the Company and each of its subsidiaries. The Committee will:<br />
(i) oversee and appraise the quality of the audit of the Company's internal audit function and of its external<br />
auditors;<br />
(ii) serve as an independent and objective party to review the financial information presented by the<br />
Management to Shareholders, regulators and general public; and<br />
(iii) examine the adequacy of the Company's administrative and operating controls as well as internal<br />
accounting controls and evaluate adherence.<br />
Annual Report 2000<br />
29